Cargando…
Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841090/ https://www.ncbi.nlm.nih.gov/pubmed/29676408 http://dx.doi.org/10.1155/2018/6156024 |
| _version_ | 1783304695656218624 |
|---|---|
| author | Miranda-Hernández, Mariana P. López-Morales, Carlos A. Perdomo-Abúndez, Francisco C. Salazar-Flores, Rodolfo D. Ramírez-Ibanez, Nancy D. Pérez, Nestor O. Molina-Pérez, Aaron Revilla-Beltri, Jorge Medina-Rivero, Emilio Flores-Ortiz, Luis F. |
| author_facet | Miranda-Hernández, Mariana P. López-Morales, Carlos A. Perdomo-Abúndez, Francisco C. Salazar-Flores, Rodolfo D. Ramírez-Ibanez, Nancy D. Pérez, Nestor O. Molina-Pérez, Aaron Revilla-Beltri, Jorge Medina-Rivero, Emilio Flores-Ortiz, Luis F. |
| author_sort | Miranda-Hernández, Mariana P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5841090 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58410902018-04-19 Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept” Miranda-Hernández, Mariana P. López-Morales, Carlos A. Perdomo-Abúndez, Francisco C. Salazar-Flores, Rodolfo D. Ramírez-Ibanez, Nancy D. Pérez, Nestor O. Molina-Pérez, Aaron Revilla-Beltri, Jorge Medina-Rivero, Emilio Flores-Ortiz, Luis F. J Immunol Res Letter to the Editor Hindawi 2018-02-21 /pmc/articles/PMC5841090/ /pubmed/29676408 http://dx.doi.org/10.1155/2018/6156024 Text en Copyright © 2018 Mariana P. Miranda-Hernández et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Miranda-Hernández, Mariana P. López-Morales, Carlos A. Perdomo-Abúndez, Francisco C. Salazar-Flores, Rodolfo D. Ramírez-Ibanez, Nancy D. Pérez, Nestor O. Molina-Pérez, Aaron Revilla-Beltri, Jorge Medina-Rivero, Emilio Flores-Ortiz, Luis F. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept” |
| title | Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept” |
| title_full | Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept” |
| title_fullStr | Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept” |
| title_full_unstemmed | Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept” |
| title_short | Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept” |
| title_sort | response to: comment on “new alternatives for autoimmune disease treatments: physicochemical and clinical comparability of biosimilar etanercept” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841090/ https://www.ncbi.nlm.nih.gov/pubmed/29676408 http://dx.doi.org/10.1155/2018/6156024 |
| work_keys_str_mv | AT mirandahernandezmarianap responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT lopezmoralescarlosa responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT perdomoabundezfranciscoc responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT salazarfloresrodolfod responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT ramirezibaneznancyd responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT pereznestoro responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT molinaperezaaron responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT revillabeltrijorge responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT medinariveroemilio responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept AT floresortizluisf responsetocommentonnewalternativesforautoimmunediseasetreatmentsphysicochemicalandclinicalcomparabilityofbiosimilaretanercept |